<DOC>
	<DOCNO>NCT01257243</DOCNO>
	<brief_summary>The purpose study evaluate efficacy combination dose oxomemazine , guaifenesin potassium iodate superior guaifenesin monotherapy acute cough treatment .</brief_summary>
	<brief_title>Comparison Between Oxomemazine , Guaifenesin Potassium Iodate Versus Guaifenesin Monotherapy Acute Cough Treatment</brief_title>
	<detailed_description>STUDY DESIGN - Open-label , superiority , prospective , parallel group , intent treat trial - Experiment duration : 7 day - 3 visit ( day 1 , 2 7 ) - Reduction cough symptom - Adverse event evaluation</detailed_description>
	<mesh_term>Cough</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine , phenylpropanolamine drug combination</mesh_term>
	<mesh_term>Potassium iodate</mesh_term>
	<criteria>1 . Patients must able understand study procedure agree participate give write consent . 2 . Patients productive cough result acute URTI ( i.e. , cold flu ) allergic cough last 10 day . 3 . Cough score superior 3 . 1 . Pregnancy risk pregnancy . 2 . Lactation . 3 . Fever 38ยบ C. 4 . Patients bacterial infection upper respiratory tract . 5 . Any pathology past medical condition interfere protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>cough</keyword>
	<keyword>symptom</keyword>
	<keyword>cold</keyword>
	<keyword>flu</keyword>
</DOC>